Skip to main content
. 2022 Jan 19;150(9):1537–1548. doi: 10.1002/ijc.33924

FIGURE 4.

FIGURE 4

ctDNA stratified relapse rates of patients with indeterminate CT findings. (A) Kaplan‐Meier estimates (CI = 95%) of recurrence free survival for 21 CRLM patients with indeterminate findings stratified by concomitant ctDNA status before first relapse. (B) Kaplan‐Meier estimates (CI = 95%) of recurrence free survival for all patients with indeterminate findings stratified by concomitant ctDNA status. A patient was called positive if a concomitant plasma sample was ctDNA positive